XNYS · Healthcare · Medical Devices
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q1 2026 | 1.07 | 1.00 | -6.07% | $374.8M | ❌ Miss | -0.83% | -0.49% | — |
| 2026-02-25 | Q4 2025 | 1.12 | 1.18 | +5.36% | $385.4M | ✅ Beat | +0.00% | +0.28% | -1.05% |
| 2025-11-05 |
| Q3 2025 |
| 0.91 |
| 0.97 |
| +6.59% |
| $354.7M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-29 | Q2 2025 | 0.82 | 0.86 | — | $339.5M | ➖ Inline | +12.70% | +5.70% | +19.60% |
| 2025-04-23 | Q1 2025 | 0.67 | 0.83 | +23.88% | $324.1M | ✅ Beat | +6.99% | +5.05% | -3.67% |
| 2025-02-18 | Q4 2024 | 0.89 | 0.97 | +8.99% | $315.5M | ✅ Beat | +12.03% | +3.87% | +3.76% |
| 2024-07-30 | Q2 2024 | 0.56 | 0.64 | +14.29% | $299.4M | ✅ Beat | -3.47% | -0.95% | +16.93% |
| 2024-05-07 | Q1 2024 | 0.38 | 0.41 | +7.89% | $278.7M | ✅ Beat | -3.29% | -0.60% | -6.47% |
Showing last 8 quarters.